U.S. Physical Therapy, Inc. (USPH)

USPH's stock has outperformed the S&P 500 by 9.5% over the past six months, achieving a 19.1% gain, partly due to solid quarterly results. In January 2026, revenue increased by 17.30%, supported by positive analyst sentiment. A new US$25,000,000 share repurchase program was authorized in November 2025. The third quarter of 2025 saw a record-high average of 32.2 daily patient visits per clinic, with the Industrial Injury Prevention (IIP) segment's revenue increasing by 14.6% year-over-year. In the second quarter of 2025, total patient visits rose by 16.7%, and average daily patient visits per clinic reached an all-time high of 32.7, with IIP revenue growing by 22.6%. The company added six clinics while closing four and completed an acquisition of an outpatient home-care physical and speech therapy practice in April 2025. The first quarter of 2025 reported a 13.9% year-over-year surge in total patient visits, reaching an all-time high of 31.4 average daily visits per clinic, and the IIP segment's revenue jumped by 28.8%. For the fourth quarter of 2024, USPH achieved a record-high average daily patient visits per clinic of 31.7, and total patient visits increased by 13.0%, with IIP revenue seeing a substantial increase of 32.1%. The stock price as of February 5, 2026, was $84.07.

While there are no explicit statements detailing strong seasonal peaks or troughs for U.S. Physical Therapy, Inc.'s services, demand can be influenced by external factors. The first quarter of 2025 experienced a loss of 26,000 patient visits due to severe weather, but a subsequent rebound suggests weather-related impacts can lead to pent-up demand. The company's CEO has indicated that physical therapy is a necessity-driven service, demonstrating resilience even during economic recessions, with past downturns resulting in only minor declines in patient volume.

U.S. Physical Therapy, Inc. (USPH) specializes in outpatient physical therapy and industrial injury prevention services. The company operates outpatient clinics and provides industrial injury prevention services, offering physical and occupational therapy, pre- and post-operative care, and rehabilitation for various conditions. Through its Industrial Injury Prevention Services segment, USPH offers onsite injury prevention, performance optimization, and ergonomic assessments to clients.

As of November 2025, U.S. Physical Therapy, Inc. operates 779 owned or managed clinics across 44 states. In October 2023, the company expanded into Colorado, marking its 42nd state for physical therapy operations. By December 31, 2024, it owned and/or managed 772 clinics in 43 states, with 39 managed on behalf of third parties as of February 28, 2025.

There have been no direct reports of events negatively impacting U.S. Physical Therapy, Inc.'s brand reputation in the past year. Consistent growth in patient visits and revenue, along with strategic acquisitions, suggests a generally positive operational standing. Management's proactive approach to mitigating reimbursement cuts through improved operational efficiency, commercial contract negotiations, and technology leverage helps maintain a strong standing. The company's clinic-based model has successfully converted rising patient demand into profitable revenue despite industry headwinds. Potential risks include governmental and third-party payor inspections, reviews, investigations, and audits that could lead to sanctions or reputational harm.

U.S. Physical Therapy, Inc.'s ownership is predominantly held by institutional investors, accounting for 105.40% of ownership, with insiders holding 9.18% and retail investors 0.00%. Major institutional owners include BlackRock Inc., Kayne Anderson Rudnick Investment Management LLC, Morgan Stanley, Vanguard Group Inc., Copeland Capital Management LLC, State Street Corp, Southernsun Asset Management LLC, Boston Trust Walden Corp, Bahl Gaynor Inc, and Dimensional Fund Advisors LP. The largest individual shareholder is J. Livingston Kosberg, who owns 2.45% of the company's shares.